首页> 美国卫生研究院文献>Systems and Synthetic Biology >On Brucella pathogenesis: looking for the unified challenge in systems and synthetic biology
【2h】

On Brucella pathogenesis: looking for the unified challenge in systems and synthetic biology

机译:关于布鲁氏菌病的发病机理:寻找系统和合成生物学的统一挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Brucellosis is a zoonotic infection transmitted to humans from infected animals and is one of the widely spread zoonoses. Recently, six species were recognized within the genus Brucella wherein B. melitensis, B. suis and B. abortus are considered virulent for humans. While these species differ phenotypically by their pattern of metabolic activities, there has been an imperative need to understand pathogenesis of Brucella species. It has been foreseen that creating a human vaccine for Brucellosis would entail decreased dose of antibiotics. However the emerging role of Brucella pathogenesis still centers on isolation of the organism and various diagnostic tests thereby leading to varying strategies of treatment cycle. In view of disease heterogeneity, we focus systems and synthetic biology challenges that might improve our understanding the Brucella pathogenesis.Electronic supplementary materialThe online version of this article (doi:10.1007/s11693-014-9158-2) contains supplementary material, which is available to authorized users.
机译:布鲁氏菌病是从被感染的动物传播给人的人畜共患疾病,是广泛传播的人畜共患病之一。最近,在布鲁氏菌属中识别出六个物种,其中认为肉芽孢杆菌,猪芽孢杆菌和流产芽孢杆菌被认为对人有毒。尽管这些物种的代谢活动模式在表型上有所不同,但迫切需要了解布鲁氏菌物种的发病机理。可以预见的是,开发用于布鲁氏菌病的人类疫苗将需要减少抗生素剂量。然而,布鲁氏菌病发病机理的新兴作用仍然集中在生物体的分离和各种诊断测试上,从而导致治疗周期策略的变化。鉴于疾病的异质性,我们关注可能会加深我们对布鲁氏菌病发病机理的系统和合成生物学挑战。电子补充材料本文的在线版本(doi:10.1007 / s11693-014-9158-2)包含补充材料给授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号